{"id":"W4402661363","doi":"10.1016/j.annonc.2024.08.2339","title":"First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Loxo Oncology; University of Texas MD Anderson Cancer Center; Amgen; Pfizer; Symphogen; GlaxoSmithKline","keywords":"Protein arginine methyltransferase 5; Medicine; Maximum tolerated dose; Cancer research; Arginine; Pharmacology; Methyltransferase; Biochemistry; Pharmacokinetics; Amino acid; Biology; Methylation; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002640857,0.0001675925,0.0003436446,0.000183664,0.0000309163,0.00001154345,0.0001159179,0.000197339,0.000009700567],"category_scores_gemma":[0.00006784872,0.0001550743,0.00003739534,0.0002914861,0.00007999481,0.00003705174,0.00005271712,0.0001311605,0.000001302781],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004857533,"about_ca_system_score_gemma":0.0002003955,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009040918,"about_ca_topic_score_gemma":0.01072236,"domain_scores_codex":[0.9982811,0.0002205093,0.0006648338,0.0004785114,0.000165747,0.000189288],"domain_scores_gemma":[0.9991056,0.00003212805,0.0002317953,0.000307659,0.0002724861,0.00005032882],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.03495428,0.03390187,0.01967764,0.0001706111,0.0009956906,0.0001406543,0.03655773,0.1130391,0.698687,0.00007209431,0.004325462,0.05747789],"study_design_scores_gemma":[0.0541663,0.1429415,0.1675466,0.0007281334,0.0001324839,0.000003027294,0.004055269,0.006030602,0.618159,0.000334822,0.004921672,0.0009806582],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984925,0.0001805485,0.00003350886,0.0002293902,0.0001120963,0.0007124246,0.0001469978,0.00001016096,0.00008236351],"genre_scores_gemma":[0.9983727,0.00004319137,0.00005076133,0.00003693429,0.0001239693,0.00005648531,0.001269336,0.00002284528,0.00002373544],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1478689,"threshold_uncertainty_score":0.6323747,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04062427101121577,"score_gpt":0.36532275548837,"score_spread":0.3246984844771542,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}